Evaluating the Impact of Quitting Using Executive Function Strategy Training (QUEST) on Smoking Cessation in Homeless Young Adult Smokers
NCT ID: NCT06745154
Last Updated: 2024-12-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
27 participants
INTERVENTIONAL
2023-06-26
2023-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Gather data needed to build QUEST (Quitting Using Executive function Strategy Training), an intervention to help youth and young adults (YYEH) with executive function dysregulation better 1) access evidence-based cessation; 2) adhere to processes of evidence-based treatment; and 3) address stress to prevent relapse.
II. Establish the feasibility of collecting acquired brain injury (ABI) status, and impact data sensitive to change over time (clinical and epigenetic), from YYEH tobacco users in community settings.
EXPLORATORY OBJECTIVE:
I. Determine if 1) executive functioning 2) mild cognitive impairment and 3) epigenetic age \& other biomarkers of health risk measures are sensitive to difference by ABI status among YYEH past week combustible tobacco users.
OUTLINE:
Patients receive access to the Ohio Tobacco Quitline, receive nicotine patches, gum, or lozenges for up to 8 weeks. Patients also participate in tobacco cessation counseling sessions for 5 sessions over 8 weeks. Patients additionally undergo cognitive assessment and nasal swab collection on study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prevention (QUEST)
Patients receive access to the Ohio Tobacco Quitline, receive nicotine patches, gum, or lozenges for up to 8 weeks. Patients also participate in tobacco cessation counseling sessions for 5 sessions over 8 weeks. Patients additionally undergo cognitive assessment and nasal swab collection on study.
Biospecimen Collection
Undergo nasal swab collection
Cognitive Assessment
Undergo cognitive assessment
Interview
Ancillary studies
Nicotine Replacement
Given nicotine patches, gum, or lozenges
Smoking Cessation Intervention
Receive access to the Ohio Tobacco Quit Line
Survey Administration
Ancillary studies
Tobacco Cessation Counseling
Participate in counseling sessions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biospecimen Collection
Undergo nasal swab collection
Cognitive Assessment
Undergo cognitive assessment
Interview
Ancillary studies
Nicotine Replacement
Given nicotine patches, gum, or lozenges
Smoking Cessation Intervention
Receive access to the Ohio Tobacco Quit Line
Survey Administration
Ancillary studies
Tobacco Cessation Counseling
Participate in counseling sessions
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Utilizing STAR House ( a drop-in center for youth and young adults experiencing homelessness) services
* Use of combustible tobacco product in the last week
* Willing to quit smoking in the next 30 days
* Acquired Brain Injury (ABI) (15 youth with and 15 without)
* CHATS will be used to determine ABI. Ask "C", "H" and "A" of the CHATS tool. If yes to C OR H and yes to A, that will be considered positive for ABI
* Have access to a phone
* Willing to use phone for QuitLine (QL) services
* Willing to enroll in Ohio Tobacco Quit Line
* Willing to share Ohio Tobacco Quit Line portal data with researchers
* Willing to provide biospecimens (exhaled air and nasal samples)
* Conversational English skills
18 Years
24 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ohio State University Comprehensive Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julianna Nemeth, PhD
Role: PRINCIPAL_INVESTIGATOR
Ohio State University Comprehensive Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
The Jamesline
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2024-04793
Identifier Type: REGISTRY
Identifier Source: secondary_id
OSU-23119
Identifier Type: -
Identifier Source: org_study_id